Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LP002 in advanced cutaneous squamous cell carcinoma
CTR20191546Phase 2Terminated
- Sponsor
- Taizhou Houde Aoke Technology
- Start
- Aug 2019
- Modality
- Vaccines & Immunotherapeutics, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of LP002 in cutaneous squamous cell carcinoma (cSCC), sponsored by Taizhou Houde Aoke Technology. Started Aug 2019; status: terminated.
02
Drugs
LP002
03
Conditions
cutaneous squamous cell carcinoma (cSCC)
Beyond the preview
Go deeper on CTR20191546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191546.